Management of ventricular arrhythmias worldwide: comparison of the latest ESC, AHA/ACC/HRS, and CCS/CHRS guidelines
H Könemann, C Ellermann, K Zeppenfeld… - Clinical …, 2023 - jacc.org
A new guideline for the management of patients with ventricular arrhythmias and the
prevention of sudden cardiac death has been published by the European Society of …
prevention of sudden cardiac death has been published by the European Society of …
[HTML][HTML] Electrical storm: prognosis and management
I Elsokkari, JL Sapp - Progress in Cardiovascular Diseases, 2021 - Elsevier
Electrical storm is present when a cluster of ventricular arrhythmias (VAs) occurs within a
short time frame. The most widely accepted definition is 3 or more episodes of VA within a …
short time frame. The most widely accepted definition is 3 or more episodes of VA within a …
[HTML][HTML] Ventricular tachycardia burden and mortality: association or causality?
M Samuel, I Elsokkari, JL Sapp - Canadian Journal of Cardiology, 2022 - Elsevier
Ventricular tachycardia (VT) is a potentially fatal cardiac rhythm disorder. Implantable
cardioverter defibrillators (ICDs) are the primary management strategy for VT and have been …
cardioverter defibrillators (ICDs) are the primary management strategy for VT and have been …
Lidocaine as an anti‐arrhythmic drug: Are there any indications left?
S Güler, H Könemann, J Wolfes, F Güner… - Clinical and …, 2023 - Wiley Online Library
Lidocaine is classified as a class Ib anti‐arrhythmic that blocks voltage‐and pH‐dependent
sodium channels. It exhibits well investigated anti‐arrhythmic effects and has been the anti …
sodium channels. It exhibits well investigated anti‐arrhythmic effects and has been the anti …
Effect of time to treatment with antiarrhythmic drugs on return of spontaneous circulation in shock‐refractory out‐of‐hospital cardiac arrest
Background The effects of amiodarone and lidocaine on the return of spontaneous
circulation (ROSC) in relation to time to treatment in patients with out‐of‐hospital cardiac …
circulation (ROSC) in relation to time to treatment in patients with out‐of‐hospital cardiac …
Catheter ablation of ventricular arrhythmia in patients with an implantable cardioverter-defibrillator: a systematic review and meta-analysis
KY Fong, YH Chan, Y Wang, C Yeo, ETS Lim… - Canadian Journal of …, 2023 - Elsevier
Background Implantable cardioverter-defibrillator (ICD) shocks are associated with higher
rates of mortality and reduced quality of life. In this study we aimed to investigate the …
rates of mortality and reduced quality of life. In this study we aimed to investigate the …
Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial
MW Deyell, S Doucette, R Parkash, I Nault, L Gula… - EP …, 2022 - academic.oup.com
Aims Catheter ablation is superior to escalated antiarrhythmic drugs among patients with
ventricular tachycardia (VT) and prior myocardial infarction (MI). However, it is uncertain …
ventricular tachycardia (VT) and prior myocardial infarction (MI). However, it is uncertain …
Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias
N Alhourani, J Wolfes, H Könemann… - Clinical Research in …, 2024 - Springer
Despite impressive developments in the field of ventricular arrhythmias, there is still a
relevant number of patients with ventricular arrhythmias who require antiarrhythmic drug …
relevant number of patients with ventricular arrhythmias who require antiarrhythmic drug …
[HTML][HTML] Management of ventricular tachycardia in patients with cardiac sarcoidosis
M Viwe, P Nery, DH Birnie - Heart Rhythm O2, 2021 - Elsevier
Sarcoidosis is a multisystem granulomatous disease with 2 different phases (inflammation
and scar). In the current era of targeted use of implantable cardioverter-defibrillators and …
and scar). In the current era of targeted use of implantable cardioverter-defibrillators and …
Ventricular tachycardia and ICD therapy burden with catheter ablation versus escalated antiarrhythmic drug therapy
M Samuel, JS Healey, I Nault, LD Sterns… - Clinical …, 2023 - jacc.org
Background Catheter ablation improves ventricular tachycardia (VT) event-free (time to
event) survival in patients with antiarrhythmic drug (AAD)-refractory VT and previous …
event) survival in patients with antiarrhythmic drug (AAD)-refractory VT and previous …